Mark Sale, MD Joins Kinetigen as VP, Modeling and Simulation (March 21, 2013) Read more

Xceleron and Kinetigen Announce Partnership to Simplify and Empower Phase I Clinical Investigations (February 26, 2013) Read more

Kinetigen to Showcase Pharmacokinetics Expertise at ASCPT Annual Meeting and Exhibition (February 21, 2013) Read more

Learn What Makes Kinetigen Different:
Video of Geoffrey Banks, PhD CEO of Kinetigen

Are We Identical or Just Similar: The Potential for “Biogenerics” (December 13, 2012) Blog posted on American Association of Pharmaceutical Scientists (AAPS) website.

Should you Include a +/- Time Window Around Collection of Pharmacokinetic Samples in a Clinical Trial? (September 05, 2012) In most instances, the short answer is NO….unless you like protocol deviations that have no use and no bearing on the analysis of PK data.

More Blogs